Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$3.01

-0.03 (-0.99%)

08:24
10/05/16
10/05
08:24
10/05/16
08:24

Fate Therapeutics issued U.S. patent protecting cellular composition of ProTmune

Fate Therapeutics announced that the USPTO issued a patent covering enhanced hematopoietic stem cell compositions. This newly-issued patent expands the company's intellectual property position covering ex vivo small molecule modulation of hematopoietic stem cells, which includes compositions and methods for enhanced lentiviral transduction and engraftment in the field of hematopoietic cell transplantation. ProTmune is an investigational programmed cellular immunotherapy undergoing clinical development for the prevention of acute graft-versus-host disease and cytomegalovirus infection in patients undergoing allogeneic hematopoietic cell transplantation. The company also has filed corresponding patent applications to seek similar patent protection for its hematopoietic stem cell compositions in key markets including Europe and Japan.

FATE Fate Therapeutics
$3.01

-0.03 (-0.99%)

04/11/16
BMOC
04/11/16
INITIATION
Target $4
BMOC
Outperform
Fate Therapeutics initiated with an Outperform at BMO Capital
Target $4.
07/28/16
HCWC
07/28/16
INITIATION
Target $9
HCWC
Buy
Fate Therapeutics assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Shaunak Deepak assumed coverage of Fate Therapeutics with a Buy rating and $9 price target.
07/28/16
07/28/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cray (CRAY) initiated with an Overweight at Pacific Crest. 2. Fate Therapeutics (FATE) assumed with a Buy at H.C. Wainwright. 3. Super Micro Computer (SMCI) initiated with a Sector Weight at Pacific Crest. 4. Stamps.com (STMP) re-initiated with a Buy at Roth Capital. 5. Ormat Technologies (ORA) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/16
ROTH
09/22/16
INITIATION
Target $8
ROTH
Buy
Fate Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Mark Breidenbach started Fate Therapeutics with a Buy rating and $8 price target.

TODAY'S FREE FLY STORIES

08:25
04/25/17
04/25
08:25
04/25/17
08:25
Conference/Events
The Washington Journal holds a discussion on Dodd-Frank »

Manhattan Institute…

WHR

Whirlpool

$174.80

3.29 (1.92%)

08:22
04/25/17
04/25
08:22
04/25/17
08:22
Hot Stocks
Whirlpool sees 3%-5% annual organic net sales growth, 10%+ EBIT margin by 2020 »

Says fundamentals of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

$DJT

DJ Transportation Average

08:21
04/25/17
04/25
08:21
04/25/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
04/25/17
04/25
08:20
04/25/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
04/25/17
04/25
08:20
04/25/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$167.06

2.65 (1.61%)

08:20
04/25/17
04/25
08:20
04/25/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
04/25/17
04/25
08:20
04/25/17
08:20
General news
U.S. chain store sales rose 0.6% in the week ended April 22 »

U.S. chain store sales…

XLK

Technology Select Sector SPDR

$53.80

0.63 (1.18%)

08:19
04/25/17
04/25
08:19
04/25/17
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$43.28

0.21 (0.49%)

08:19
04/25/17
04/25
08:19
04/25/17
08:19
Hot Stocks
Coca-Cola sees FY17 net CapEx $2B-$2.5B »

Sees FY17 net share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 09

    May

XLE

Energy Select Sector SPDR

$68.19

0.4 (0.59%)

08:19
04/25/17
04/25
08:19
04/25/17
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$88.82

0.57 (0.65%)

08:19
04/25/17
04/25
08:19
04/25/17
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$33.82

0.14 (0.42%)

08:19
04/25/17
04/25
08:19
04/25/17
08:19
Initiation
Sony initiated  »

Sony initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

XLB

S&P Select Materials SPDR

$52.80

0.6 (1.15%)

08:19
04/25/17
04/25
08:19
04/25/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$39.30

0.19 (0.49%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Recommendations
Coach analyst commentary  »

Coach risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$52.00

0.27 (0.52%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$55.50

0.5 (0.91%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$74.41

0.73 (0.99%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$90.68

1.57 (1.76%)

, VA

Virgin America

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Hot Stocks
Alaska Air and Virgin America to move into terminal 7 at JFK airport »

Alaska Airlines (ALK) and…

ALK

Alaska Air

$90.68

1.57 (1.76%)

VA

Virgin America

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 04

    May

  • 10

    May

IWM

iShares Trust Russell 2000 Index Fund

$138.92

1.71 (1.25%)

08:18
04/25/17
04/25
08:18
04/25/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$43.28

0.21 (0.49%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Hot Stocks
Coca-Cola CEO says Q1 results 'in line with our plan' »

Muhtar Kent, Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 09

    May

DIA

Diamonds Fund ETF

$207.38

2.13 (1.04%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$237.17

2.58 (1.10%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$23.68

0.52 (2.25%)

08:17
04/25/17
04/25
08:17
04/25/17
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$79.75

1.14 (1.45%)

08:16
04/25/17
04/25
08:16
04/25/17
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

NASDAQ 100 Index Tracking Stock

$134.16

1.6 (1.21%)

08:16
04/25/17
04/25
08:16
04/25/17
08:16
Technical Analysis
NASDAQ 100 Index Tracking Stock: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.